Physician profile
David C Ring
NPI 1568452746
$536,308.53
in general payments reported to CMS, 2019-2025
8 companies · $17K in 2025
The $17K reported for 2025 was more than what 95% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68K · 2020: $81K · 2021: $83K · 2022: $107K · 2023: $102K · 2024: $78K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $184K · Consulting Fee: $6,720 · Travel and Lodging: $5,976 · Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $184,265.08 |
| Consulting Fee | $6,720.00 |
| Travel and Lodging | $5,976.13 |
| Food and Beverage | $184.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Skeletal Dynamics INC | $516,682.82 | 2019-2025 | Geminus, Ijs, Align |
| Vertex Pharmaceuticals Incorporated | $12,202.82 | 2024 | |
| Synthes Gmbh | $4,823.40 | 2019-2021 | |
| Wright Medical Technology, INC. | $1,763.85 | 2019 | |
| Pfizer INC. | $630.00 | 2023 | |
| Globus Medical, INC. | $139.55 | 2022 | |
| Stryker Corporation | $48.04 | 2025 | T2 Alpha |
| Innovation Technologies INC | $18.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ring listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.